Entero Therapeutics (ENTO) Financial Statements

Entero Therapeutics's market cap is currently $9.38M. The company's EPS TTM is $-6.65; its P/E ratio is ―; Entero Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.